Advertisement

Prognosis and Staging

  • Qin Huang
  • Jason S. Gold
Chapter

Abstract

Prognosis of patients with gastric cardiac cancer is significantly correlated to pathologic tumor-node-metastasis stages. The most important difference in prognosis between patients with gastric cardiac cancer and those with esophageal adenocarcinoma is the stage III disease. Because prognosis of patients with gastric cardiac cancer can be better stratified by the staging rules for gastric cancer, both the International Gastric Cancer Association and the American Joint Committee on Cancer (the eighth edition) published the staging guidelines in 2017 and required staging this cancer with the scheme for gastric cancer. Pathologists have to thoroughly evaluate resection specimens and appropriately stage each case with a complete synoptic report for patient triage, cancer registry data collection, and clinicopathologic research.

Keywords

Gastric cancer Gastric cardiac cancer Stomach Cancer Staging AJCC 

References

  1. 1.
    American Joint Committee on Cancer. Chapter 10. Esophagus and esophagogastric junction. In: AJCC cancer staging manual. 7th ed. New York, NY: Springer; 2009. p. 129–44.Google Scholar
  2. 2.
    Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Wijnhoven BP, Siersema PD, Hop WC, et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg. 1999;86:529–35.CrossRefPubMedGoogle Scholar
  4. 4.
    Chandrasoma P, Wickramasinghe K, Ma Y, et al. Adenocarcinomas of the distal oesophagus and “gastric cardia” are predominantly esophageal carcinomas. Am J Surg Pathol. 2007;31:569–75.CrossRefPubMedGoogle Scholar
  5. 5.
    Fang WL, Wu CW, Chen JH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol. 2009;16(12):3237–44.CrossRefPubMedGoogle Scholar
  6. 6.
    Kwon SJ. Evaluation of the 7th UICC TNM Staging System of Gastric Cancer. J Gastric Cancer. 2011;11(2):78–85.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Huang Q, Shi J, Feng AN, et al. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer staging system. Mod Pathol. 2011;24:138–46.CrossRefPubMedGoogle Scholar
  8. 8.
    Suh YS, Han DS, Kong SH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC classification. Ann Surg. 2012;255:908–15.CrossRefPubMedGoogle Scholar
  9. 9.
    Huang Q. Unique clinicopathology of proximal gastric carcinoma: a critical review. Gastroint Tumors. 2014;1:115–22.CrossRefGoogle Scholar
  10. 10.
    Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int J Surg Pathol. 2007;15:38–42.CrossRefPubMedGoogle Scholar
  11. 11.
    Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastro. 2012;18(48):7134–40.CrossRefGoogle Scholar
  12. 12.
    Sano T, Coit DG, Kim HH, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2017;20:217–25.CrossRefPubMedGoogle Scholar
  13. 13.
    American Joint Committee on Cancer. Chapter 17. Stomach. In: AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2017. p. 203–20.Google Scholar
  14. 14.
    Whitson BA, Groth SS, Li Z, Kratzke RA, Maddaus MA. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas. Thorac Cardiovasc Surg. 2010;139(1):43–8.CrossRefGoogle Scholar
  15. 15.
    Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010. p. 48–58.Google Scholar
  16. 16.
    Huang Q, Sun Q, Fan XS, Zhou D, Zou XP. Recent advances in proximal gastric carcinoma. J Dig Dis. 2016;17(7):421–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  18. 18.
    Patel MI, Rhoads KF, Ma Y, et al. Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement? Ann Surg Oncol. 2013;20(5):1631–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Huang Q, Fan XS, Agoston AT, et al. Comparison of gastroesophageal junction carcinomas in Chinese versus American patients. Histopathology. 2011;59(2):188–97.CrossRefPubMedGoogle Scholar
  20. 20.
    Li R, Chen TW, Hu J, et al. Tumor volume of resectable adenocarcinoma of the esophagogastric junction at multidetector CT: association with regional lymph node metastasis and N stage. Radiology. 2013;269(1):130–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Gertler R, Stein HJ, Loos M, Langer R, Friess H, Feith M. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol. 2011;35:1512–22.CrossRefPubMedGoogle Scholar
  22. 22.
    Okholm C, Svendsen LB, Achiam MP. Status and prognosis of lymph node metastasis in patients with cardia cancer—a systematic review. Surg Oncol. 2014;23(3):140–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg. 2014;259(1):96–101.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhao E, Ling T, Xu J, et al. Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution. Int J Clin Exp Med. 2015;8(7):10668–77.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Huang Q, Shi J, Sun Q, et al. Distal esophageal carcinomas in Chinese patients vary widely in histopathology, but adenocarcinomas remain rare. Hum Pathol. 2012;43(12):2138–48.CrossRefPubMedGoogle Scholar
  26. 26.
    Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Tsubosa Y, Terashima M. Impact of esophageal invasion on clinicopathological characteristics and long-term outcome of adenocarcinoma of the subcardia. J Surg Oncol. 2012;106(7):856–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Ielpo B, Pernaute AS, Elia S, et al. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction. Interact Cardiovasc Thorac Surg. 2010;10(5):704–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Kim HI, Cheong JH, Song KJ, et al. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems. Ann Surg Oncol. 2013;20(8):2713–20.CrossRefPubMedGoogle Scholar
  29. 29.
    Zhang YF, Shi J, Yu HP, et al. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastro. 2012;18(27):3602–9.CrossRefGoogle Scholar
  30. 30.
    Zhang HD, Ma Z, Tang P, et al. Prognostic value of metastatic lymph node ratio in adenocarcinoma of the gastroesophageal junction. Zhonghua Wei Chang Wai Ke Za Zhi. 2013;16(9):822–6. (in Chinese).PubMedGoogle Scholar
  31. 31.
    Roviello F, Marrelli D, Morgagni P, et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol. 2002;9(9):894–900.CrossRefPubMedGoogle Scholar
  32. 32.
    de Manzoni G, Verlato G, Guglielmi A, et al. Classification of lymph node metastases from carcinoma of the stomach: comparison of the old (1987) and new (1997) TNM systems. World J Surg. 1999;23(7):664–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Mönig SP, Baldus SE, Zirbes TK, et al. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. Hepato-Gastroenterology. 2002;49(44):419–22.PubMedGoogle Scholar
  34. 34.
    Matsuda T, Takeuchi H, Tsuwano S, Nakahara T, Mukai M, Kitagawa Y. Sentinel node mapping in adenocarcinoma of the esophagogastric junction. World J Surg. 2014;38(9):2337–44.CrossRefPubMedGoogle Scholar
  35. 35.
    Kurokawa Y, Hiki N, Yoshikawa T, et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery. 2015;157(3):551–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Matsuda T, Kurokawa Y, Yoshikawa T, et al. Clinicopathological characteristics and prognostic factors of patients with Siewert Type II esophagogastric junction carcinoma: a retrospective multicenter study. World J Surg. 2016;40(7):1672–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRefGoogle Scholar
  38. 38.
    Nunobe S, Ohyama S, Sonoo H, et al. Benefit of mediastinal and para-aortic lymph-node dissection for advanced gastric cancer with esophageal invasion. J Surg Oncol. 2008;97(5):392–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Schomas DA, Quevedo JF, Donahue JM, Nichols Iii FC, Romero Y, Miller RC. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic. Dis Esophagus. 2010;23(3):232–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Mariette C, Castel B, Toursel H, Balon JM, Triboulet JP. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg. 2002;89:1156–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006;24(26):4347–55.CrossRefPubMedGoogle Scholar
  42. 42.
    Feng F, Sun L, Liu Z, et al. Prognostic values of normal preoperative serum cancer markers for gastric cancer. Oncotarget. 2016;7(36):58459–69.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Qin Huang
    • 1
    • 2
  • Jason S. Gold
    • 3
    • 4
  1. 1.Pathology and Laboratory MedicineVeterans Affairs Boston Healthcare SystemWest RoxburyUSA
  2. 2.Harvard Medical School and Brigham and Women’s HospitalBostonUSA
  3. 3.Department of Surgery, Harvard Medical School/Brigham and Women’s HospitalBostonUSA
  4. 4.Veterans Affairs Boston Healthcare SystemWest RoxburyUSA

Personalised recommendations